Anzahl der Publikationen: 5
Zeitschriftenartikel
Jodeleit, Henrika; Winkelmann, Paula; Caesar, Janina; Sterz, Sebastian; Holdt, Lesca M.; Beigel, Florian; Stallhofer, Johannes; Breiteneicher, Simone; Bartnik, Eckart; Leeuw, Thomas; Siebeck, Matthias ORCID: https://orcid.org/0000-0001-5290-5344 und Gropp, Roswitha ORCID: https://orcid.org/0000-0003-4756-261X
(2021):
Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells.
In: Disease Models & Mechanisms, Bd. 14, Nr. 1, dmm046995
[PDF, 3MB]
Jodeleit, Henrika; Winkelmann, Paula; Caesar, Janina; Sterz, Sebastian; Holdt, Lesca M.; Beigel, Florian; Stallhofer, Johannes; Breiteneicher, Simone; Bartnik, Eckart; Leeuw, Thomas; Siebeck, Matthias und Gropp, Roswitha
(2021):
Head-to-head study of oxelumab and adalimumab in a mouse reconstituted with human peripheral blood mononuclear cells.
In: Disease Models & Mechanisms, Bd. 14, Nr. 1
Unterweger, Anna-Lena; Jensen, Morten O.; Giordanetto, Fabrizio; Jogini, Vishwanath; Rueschher, Alena; Seuss, Marietta; Winkelmann, Paula; Koletzko, Leandra; Shaw, David E.; Siebeck, Matthias; Gropp, Roswitha; Beigel, Florian und Aszodi, Attila
(2021):
Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanised Mouse Model of Ulcerative Colitis.
In: Journal of Crohns & Colitis, Bd. 15, Nr. 11: S. 1943-1958
Unterweger, Anna-Lena; Rüscher, Alena; Seuß, Marietta; Winkelmann, Paula; Beigel, Florian; Koletzko, Leandra; Breiteneicher, Simone; Siebeck, Matthias; Gropp, Roswitha und Aszodi, Attila
(2021):
NOD/scid IL-2R gamma(null) mice reconstituted with peripheral blood mononuclear cells from patients with Crohn's disease reflect the human pathological phenotype.
In: Immunity Inflammation and Disease, Bd. 9, Nr. 4: S. 1631-1647
[PDF, 10MB]
Winkelmann, Paula; Unterweger, Anna-Lena; Khullar, Diya; Beigel, Florian; Koletzko, Leandra; Siebeck, Matthias und Gropp, Roswitha
(2021):
The PI3K pathway as a therapeutic intervention point in inflammatory bowel disease.
In: Immunity Inflammation and Disease, Bd. 9, Nr. 3: S. 804-818
[PDF, 3MB]
Diese Liste wurde am
Sun Nov 24 00:01:53 2024 CET
erstellt.